Global Information
회사소개 | 문의 | 위시리스트

북미의 바이러스 검사 및 미생물 검사 시장 : 주요 미생물 검사의 판매액 및 판매량, 경쟁 전략, 의료기기, 기술, 시장 기회

2017 North America Virology and Bacteriology Testing Market: Canada, Mexico, US--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

리서치사 Venture Planning Group
발행일 상품 코드 439427
페이지 정보 영문 1045 Pages
가격
US $ 7,500 ₩ 9,192,000 DataPack
US $ 9,950 ₩ 12,195,000 PDF by E-mail (Local license)
US $ 21,500 ₩ 26,352,000 PDF by E-mail (Global license)


북미의 바이러스 검사 및 미생물 검사 시장 : 주요 미생물 검사의 판매액 및 판매량, 경쟁 전략, 의료기기, 기술, 시장 기회 2017 North America Virology and Bacteriology Testing Market: Canada, Mexico, US--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities
발행일 : 페이지 정보 : 영문 1045 Pages

북미 국가(미국, 캐나다, 멕시코)의 바이러스 검사 및 미생물 검사 시장을 분석했으며, 검사 방법 개요 및 현재 기술 수준, 주요 검사약, 국가별·검사 항목별·검정 방법별 시장 규모 동향 전망, 주요 공급업체의 개요·제품 포트폴리오·사업 전략, 향후 시장 기회 등을 조사·추산하여 전해드립니다.

목차 : 도표

  • 캐나다
    • 감염증 검사 건수 예측 : 검정 방법별
    • 감염증 진단약 시장 규모 예측 : 검정 방법별
  • 멕시코
    • 감염증 검사 건수 예측 : 검정 방법별
    • 감염증 진단약 시장 규모 예측 : 검정 방법별
  • 미국
    • 시장 상황 개요(표)
    • 감염증 검사 건수·진단약 매출액의 전체적인 예측 : 부문별
    • 감염증 검사를 시행하고 있는 검사실 건수
    • 감염증 검사를 시행하고 있는 병원 건수
    • 감염증 검사를 시행하고 있는 독립/민간 검사실 건수
    • 감염증 검사를 시행하고 있는 개업의 건수
    • 감염증 검사 건수 예측 : 전체적 예측
    • 감염증 검사 건수 예측 : 검정 방법별
    • 병원에서의 감염증 검사 건수 예측
    • 혈액은행 시험실에서의 감염증 검사 건수 예측
    • 개업의에서의 감염증 검사 건수 예측
    • 독립/민간 검사실에서의 감염증 검사 건수 예측
    • 공영 위생검사실에서의 감염증 검사 건수 예측
    • 감염증 진단약 시장 규모 예측 : 전체적 예측
    • 감염증 진단약 시장 규모 예측 : 검정 방법별
    • 병원용 감염증 진단약 시장 규모 예측
    • 혈액은행 시험실용 감염증 진단약 시장 규모 예측
    • 개업의용 감염증 진단약 시장 규모 예측
    • 독립/민간 검사실용 감염증 진단약 시장 규모 예측
    • 공영 위생검사실용 감염증 진단약 시장 규모 예측
    • 각종 질환의 검사 건수/진단약 매출액 예측
      • HIV 또는 HIV I/HIV II/Combo 검사
      • HIVAg
      • 웨스턴 블롯법/기타 확인 검사
      • 아데노바이러스
      • 아에로모나스균
      • 세균성 혈관종증(BEA)
      • 블라스토시스티스 호미니스
      • 캄필로박터
      • 칸디다
      • 카바페네마제
      • 연성하감
      • 클라미디아
      • 클로스트리듐
      • 코로나바이러스
      • 콕사키바이러스
      • 크립토스포리듐
      • 시클로스포라
      • 거대세포바이러스(CMV)
      • 대장균
      • 에코바이러스
      • 뇌염
      • 엔테로바이러스
      • 엡스타인 바 바이러스(EBV)
      • 지아르디아
      • 임질
      • 서혜부 육아종
      • 한타바이러스
      • 헬리코박터 파일로리
      • A형 간염 바이러스 NAT(핵산 증폭 검사)
      • B형 간염 바이러스 NAT(핵산 증폭 검사)
      • HbsAg
      • C형 간염 바이러스
      • C형 간염 바이러스 NAT(핵산 증폭 검사)
      • C형 간염
      • 항HBC 검사
      • 항HBS 검사
      • 항HAV 검사
      • 간염 델타 검사
      • HBcAg
      • HBeAg
      • ALT/SGPT
      • 단순포진 I/II
      • 헤르페스 VI형
      • HTLV I 또는 HTLV I/HTLV II
      • 인플루엔자
      • 레지오넬라
      • 라임병
      • 림프육아종
      • 말라리아
      • 홍역
      • 수막염
      • 단핵증
      • 볼거리
      • 마이코플라스마
      • 노로바이러스
      • 파필로마
      • 파보바이러스
      • 폐렴
      • 폴리오마바이러스
      • 녹농균(슈도모나스)
      • 광견병
      • 호흡기세포융합바이러스(RSV)
      • 라이노바이러스
      • 로타바이러스
      • 풍진
      • 살모넬라균
      • 패혈증
      • 세균성 이질
      • 포도상구균
      • 연쇄구균
      • 매독
      • 톡소플라스마증
      • 트리코모나스
      • 결핵
      • 비브리오
      • 웨스트 나일 바이러스
      • 예르시니아
    • 진단약 매출액 : 주요 공급업체의 시장 점유율
      • AIDS
      • 아데노바이러스
      • 캄필로박터
      • 칸디다
      • 카바페네마제
      • 연성하감
      • 클라미디아
      • 사이트메가로·바이러스(CMV)
      • 크립토스포리듐
      • 에코바이러스
      • 엔테로바이러스
      • 엡스타인 바 바이러스(EBV)
      • 지아르디아
      • 임질
      • 헤리코바크타헬리코박터 파일로리
      • 간염
      • C형 간염
      • 포진
      • 인플루엔자
      • 레지오넬라
      • 관절염
      • 홍역
      • 수막염
      • 단핵증
      • 볼거리
      • 마이코플라스마
      • 노로바이러스
      • 폐렴
      • 광견병
      • 호흡기세포융합바이러스(RSV)
      • 로타바이러스
      • 풍진
      • 살모넬라균
      • 패혈증
      • 세균성 이질
      • 연쇄구균
      • 매독
      • 톡소플라스마증
  • 에이즈(AIDS) 검사약을 개발·출시하고 있는 주요 기업
  • 아데노바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 바르토넬라 검사약을 개발·출시하고 있는 주요 기업
  • 캄필로박터 검사약을 개발·출시하고 있는 주요 기업
  • 칸디다 검사약을 개발·출시하고 있는 주요 기업
  • 카바페네마제 검사약을 개발·출시하고 있는 주요 기업
  • 클라미디아 검사약을 개발·출시하고 있는 주요 기업
  • 클로스트리듐 검사약을 개발·출시하고 있는 주요 기업
  • 코로나바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 크립토스포리듐 검사약을 개발·출시하고 있는 주요 기업
  • 거대세포바이러스(CMV) 검사약을 개발·출시하고 있는 주요 기업
  • 에코바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 엔테로바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 엡스타인 바 바이러스(EBV) 검사약을 개발·출시하고 있는 주요 기업
  • 지아르디아 검사약을 개발·출시하고 있는 주요 기업
  • 임질 검사약을 개발·출시하고 있는 주요 기업
  • 한타바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 헬리코박터 파일로리 검사약을 개발·출시하고 있는 주요 기업
  • 간염 검사약을 개발·출시하고 있는 주요 기업
  • 헤르페스 검사약을 개발·출시하고 있는 주요 기업
  • 인플루엔자 검사약을 개발·출시하고 있는 주요 기업
  • 레지오넬라균 검사약을 개발·출시하고 있는 주요 기업
  • 라임병 검사약을 개발·출시하고 있는 주요 기업
  • 림프육아종 검사약을 개발·출시하고 있는 주요 기업
  • 말라리아 검사약을 개발·출시하고 있는 주요 기업
  • 홍역 검사약을 개발·출시하고 있는 주요 기업
  • 수막염 검사약을 개발·출시하고 있는 주요 기업
  • 미포자충목 검사약을 개발·출시하고 있는 주요 기업
  • 단핵증 검사약을 개발·출시하고 있는 주요 기업
  • 볼거리 검사약을 개발·출시하고 있는 주요 기업
  • 마이코플라스마 검사약을 개발·출시하고 있는 주요 기업
  • 노로바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 유두종 바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 파보바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 폐렴 검사약을 개발·출시하고 있는 주요 기업
  • 호흡기세포융합바이러스(RSV) 검사약을 개발·출시하고 있는 주요 기업
  • 로타바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 풍진 검사약을 개발·출시하고 있는 주요 기업
  • 살모넬라균 검사약을 개발·출시하고 있는 주요 기업
  • 패혈증 검사약을 개발·출시하고 있는 주요 기업
  • 세균성 이질 검사약을 개발·출시하고 있는 주요 기업
  • 포도상구균 검사약을 개발·출시하고 있는 주요 기업
  • 연쇄구균 검사약을 개발·출시하고 있는 주요 기업
  • 매독 검사약을 개발·출시하고 있는 주요 기업
  • 톡소플라스마증 검사약을 개발·출시하고 있는 주요 기업
  • 트리코모나스 검사약을 개발·출시하고 있는 주요 기업
  • 결핵 검사약을 개발·출시하고 있는 주요 기업
  • 웨스트 나일 바이러스 검사약을 개발·출시하고 있는 주요 기업
  • 예르시니아 검사약을 개발·출시하고 있는 주요 기업
KSA 17.03.02

This new report from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Canada, Mexico, US

Market Segmentation Analysis

- Sales and market shares of major suppliers of infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:

- Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.

- Companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 1,045 pages and 181 tables

Table of Contents

List of Tables

  • Canada
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Canada
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • Mexico
  • All Market Segments Infectious Disease Test Volume Forecast by Assay
  • Mexico
  • All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
  • U.S.A. Summary Table
  • All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Laboratories Performing Infectious Disease Tests by Market Segment
  • U.S.A.
  • Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • U.S.A.
  • Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • U.S.A.
  • Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
  • U.S.A.
  • All Market Segments Infectious Disease Test Volume Forecast
  • U.S.A.
  • All Market Segments Infectious Disease Test Volume by Method
  • U.S.A.
  • Hospital Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Blood Banks Infectious Disease Test Volume Forecast
  • U.S.A.
  • Physician Office Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Public Health Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Blood Banks Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Public Health Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • HIV or HIV I/HIV II/Combo Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Carbapenemase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HCV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HCV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Norovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Carbapenemase Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Influenza Testing Market Diagnostics Sales
  • by Major Supplier
  • U.S.A.
  • Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Norovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Carbapenemase Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Norovirus Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
Back to Top
전화 문의
F A Q